-
Posted by
Two Blokes Fri at 1:00 PM -
Filed in
Stock
-
3 views
Madrigal Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of its Rezdiffra treatment for adults with the liver disease noncirrhotic MASH who have moderate to advanced fibrosis.
